Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod

Neurology

Volumn 79, Issue 19, 2012, Pages 2006-2007

  Gross, Claus Michael ^a   Baumgartner, Annette ^a   Rauer, Sebastian ^a,b   Stich, Oliver ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RAVO DIAGNOSTIKA GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BETA1A INTERFERON; FINGOLIMOD; GADOLINIUM; METHYLPREDNISOLONE; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; ATAXIA; CASE REPORT; CORTICOSTEROID THERAPY; CRANIAL NEUROPATHY; DRUG MEGADOSE; DRUG WITHDRAWAL; FACIAL NERVE DISEASE; FACIAL NERVE PARALYSIS; FOLLOW UP; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HERPES ZOSTER OTICUS; HUMAN; LYMPHOCYTOPENIA; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PRIORITY JOURNAL; REVIEW; TRIGEMINAL NERVE DISEASE; VERTIGO; VESTIBULOCOCHLEAR NERVE DISEASE;

EID: 84871187559     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182735d24     Document Type: Article

References (7)

1. Cohen JA, Chun J. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. Ann Neurol 2011; 69:759-777.
2. Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010;362:402-415.
3. Sotelo J, Martinez-Palomo A, Ordonez G, Pineda B. Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis. Ann Neurol 2008;63:303-311.
4. Christensen T. Human herpesviruses in MS. Int J MS 2007;14:41-47.
5. Tan IL, McArthur JC, Clifford DB, Major EO, Nath A. Immune reconstitution inflammatory syndrome in natalizumabassociated PML. Neurology 2011;77:1061-1067.
6. Newsome SD, Nath A. Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neurovirol 2009;15:288-291.
7. Miravalle A, Jensen R, Kinkel RP. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol 2011;68:186-191.